Basic Information

3450 S. Broadmont
TUCSON, AZ, 85710-

Company Profile


Additional Details

Field Value
DUNS: 141832860
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a

  1. The Transfusion Chip: Phase II Technology Validation

    Amount: $1,732,966.00

    DESCRIPTION (provided by applicant): Blood-Typing is the progenitor of the entire field of personalized medicine. In the recently awarded 6-month Phase I, we proposed to take the first step in the dev ...

    SBIR Phase II 2013 Department of Health and Human Services
  2. The Transfusion Chip: A Simple, Low Cost Microarray for DNA Based Blood Typing

    Amount: $115,762.00

    DESCRIPTION (provided by applicant): Low-cost nucleic acid analysis, to detect HIV and HBV, has revolutionized screening of the blood supply. In spite of that new genetic sophistication, traditional b ...

    SBIR Phase I 2011 Department of Health and Human Services
  3. A Low Cost Microarray for Population-Scale AIDS Risk Analysis: The AIDS Chip

    Amount: $599,686.00

    DESCRIPTION (provided by applicant): There is rapidly growing HIV literature, which has discovered a set of inherited genetic differences which can predict: a) the fraction of an infected population w ...

    SBIR Phase I 2009 Department of Health and Human Services
  4. HLA Chip Product for FDA 510K Approval

    Amount: $2,513,350.00

    DESCRIPTION (provided by applicant): We describe here a Phase II Competitive Renewal grant application, which will support a three year program of ASHI (American Society of Histocompatibility and I ...

    SBIR Phase II 2009 Department of Health and Human Services

    Amount: $2,798,130.00

    DESCRIPTION (provided by applicant): Current technology for HLA typing does not have rapid field response capability because it too expensive and is too complicated to be implemented in the context of ...

    SBIR Phase II 2006 Department of Health and Human Services
  6. Population-scale HLA typing for home land defense

    Amount: $498,784.00

    DESCRIPTION (provided by applicant): Genomics USA, Inc. (GUSA) is a biotech start-up focused on microarray technology development. GUSA has previously developed a combination of genomics IT and micro ...

    SBIR Phase I 2004 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government